These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4048798)

  • 21. Evaluation of serum rosette inhibitory factors in chronic liver disease.
    Zauli D; Bianchi FB; Fusconi M; Crespi C; Pisi E
    Clin Exp Immunol; 1983 Jul; 53(1):145-50. PubMed ID: 6603304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Criteria for immunosuppressive treatment (corticotherapy) in the early stage of chronic viral hepatitis.
    Miron C; Stoica G; Angelescu M; Michiu V; Rădulescu E; Tănăsescu C
    Med Interne; 1980; 18(4):391-9. PubMed ID: 7455584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ineffectiveness of corticosteroids in cholestatic forms of chronic active hepatitis].
    Degos F; Degott C; Erlinger S
    Gastroenterol Clin Biol; 1980 Apr; 4(4):246-50. PubMed ID: 7188271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment with hepatoprotectors of patients with chronic liver diseases].
    Iakhontova OI; Dudanova OP
    Vrach Delo; 1990 May; (5):18-20. PubMed ID: 2396385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
    Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
    Gupta RC
    Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Humoral and cell-mediated immunity in the comparison of autologous hepatocytes in chronic active viral and autoimmune hepatitis].
    Mazzetti M; Zunarelli P; Cicognani G; Tisselli N; Pignatelli M; Baldini R; Pirillo L; Stefanini GF
    G Clin Med; 1982 Oct; 63(10):678-87. PubMed ID: 6985033
    [No Abstract]   [Full Text] [Related]  

  • 31. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological studies of glomerulonephritis].
    Belovezhdov N; Altŭnkova I
    Vutr Boles; 1981; 20(4):38-46. PubMed ID: 7303639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
    Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of circulating immune complexes in chronic hepatopathies].
    Delsignore R; Baroni MC; Mineo F; Conversi E; Campana G; Butturini U
    G Clin Med; 1984; 65(9-10):389-94. PubMed ID: 6530118
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different levels of lymphocyte adenosine deaminase in active and inactive forms of chronic liver disease.
    Nardiello S; Russo M; Pizzella T; Galanti B
    J Clin Lab Immunol; 1983 Aug; 11(4):177-80. PubMed ID: 6608001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The abnormality of immune status and its correction in patients with chronic pancreatitis].
    Suleĭmanov SF
    Vopr Pitan; 2008; 77(5):45-8. PubMed ID: 19048888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of the appearance and dynamics of immune complexes in patients with chronic hepatitis].
    Bozić M; Milosević-Jovcić N; Cvorić M; Nikolić V; Tosić Lj
    Srp Arh Celok Lek; 1983 Jul; 111(7):889-903. PubMed ID: 6675191
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effects of occupational exposure to nitrogen dioxide (NO2) on the immunological parameters in workers].
    Rutowski J; Moszczyński P; Dobrowolski JW; Bem S; Krochmal D
    Med Pr; 1998; 49(4):341-51. PubMed ID: 9816580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.